The experience of two European preimplantation genetic diagnosis centres on human leukocyte antigen typing

Hum Reprod. 2009 Mar;24(3):732-40. doi: 10.1093/humrep/den423. Epub 2008 Dec 5.

Abstract

Background: Two European centres report on human leukocyte antigen (HLA) typing of preimplantation embryos for haematopoietic stem cell (HSC) transplantation: 'UZ Brussel' in Brussels and 'Genoma' in Rome. Both centres have 6 years' experience with technical and clinical aspects of this type of genetic analysis on single blastomeres.

Methods: Both centres apply a similar technique for preimplantation HLA typing using short tandem repeats linked to the HLA locus in multiplex PCR for haplotyping.

Results: At present, a conclusive HLA diagnosis could be assured in 92.8% and 90.3% of the embryos at UZ Brussel and at Genoma, respectively. The implantation rates were 32.4% and 28.2%, respectively, and the birth rates per cycle were 9.4% and 18.6%, respectively. The HLA programme at UZ Brussel and at Genoma resulted in the birth of 9 babies and 3 successful HSC transplantations, and 42 babies and 7 successful HSC transplantations, respectively, so far.

Conclusions: Drastic embryo selection for preimplantation HLA typing (in theory 1/4 for HLA, 1/8 for HLA in combination with sexing for X-linked recessive diseases, 3/16 for HLA in combination with autosomal recessive disorders) resulted overall in the birth of 51 babies (15.9% live birth rate per started cycle) in two European centres.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alleles
  • Belgium
  • Female
  • Genetic Markers
  • Haplotypes
  • Hematopoietic Stem Cell Transplantation / methods*
  • Histocompatibility Testing / methods*
  • Humans
  • Italy
  • Male
  • Maternal Age
  • Pregnancy
  • Pregnancy Outcome
  • Preimplantation Diagnosis / methods*

Substances

  • Genetic Markers